[1]
2024. The High Resolution MASS spectrometry in Personalised Medicine: Retinol-Binding Protein 4 as a Candidate Biomarker Predictor of Progression in Bladder Urothelial Carcinoma. Acta Urológica Portuguesa. 38, 1-2 (Jan. 2024), 12–17. DOI:https://doi.org/10.24915/aup.156.